Jing Ren

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 19, 2025
Efficacy observation of sequential TAS-102 following regorafenib as a later-line treatment in patients with metastatic colorectal cancer: a cohort study.

Chang Xu, Xiangyu Cheng, Changqing Liu

|Dec 23, 2024
A multicenter retrospective study of the combination of immune checkpoint inhibitors and chemotherapy regimens with or without liver metastasis for the first-line treatment of advanced gastric cancer.

Jing Ren, Ke Wang, Qianhao Meng

|Nov 19, 2024
A comparison between single and fractionated doses of albumin-bound paclitaxel in the treatment of advanced esophageal cancer: A multicenter case-control study.

Jing Ren, Ke Wang, Jian Zhao

|Jul 18, 2024
Envafolimab Inhibits the Growth of Gastric Cancer Cells with Low PD-L1 Expression through the DDX20/NF-κB/TNF-α Signaling Pathway.

Zhuanxia Dong, Zefeng Yang, Jing Ren

Pageof 1

Frequent Collaborators

4 joint publications

Guangyu Wang

3 joint publications

Yusheng Wang

3 joint publications

Chang Xu

2 joint publications

Ke Wang